

The CNS market in India is estimated to be around Rs 1,200 crore of which Torrent has a 5.5 per cent share. This includes Parkinsons', Alzheimers's and depression that are some of the most prevalent ailments in this segment.

The new CNS division, Sensa, will focus exclusively on the ailments inflicting the geriatric population.

Omega will complement Torrent's existing C&D divisions, Azuca, Delta and Psycan and will help the company increase its market share considerably. Torrent, with sales of Rs 180 crore, currently has a 4.8 per cent share in the Rs 3,750 crore C&D market. Omega, the new cardio-diabeta (C&D) division, will exclusively focus on the cardio-metabolic diseases, with special focus on diabetes and nephrology. 'The launch of these exclusive divisions will not only strengthen the company's presence in these high growth potential segments but will also substantially improve its topline,' according to a release issued here today. The new divisions will cater exclusively to the fast growing niche therapeutic areas of Cardio-Diabeta, Central Nervous System and Gastro segments respectively. Ahmedabad, Oct 6 (UNI) Ahmedabad-based pharma major, the Rs 1,033 crores Torrent Pharma has launched three specialty divisions - Omega, Sensa and Alfa.
